HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,918 | +118.4% | 14,070 | +30.3% | 0.00% | – |
| Q3 2022 | $5,000 | +150.0% | 10,800 | +485.4% | 0.00% | – |
| Q1 2022 | $2,000 | -83.3% | 1,845 | -81.7% | 0.00% | – |
| Q4 2021 | $12,000 | -83.8% | 10,109 | -79.1% | 0.00% | – |
| Q3 2021 | $74,000 | +60.9% | 48,351 | +110.2% | 0.00% | – |
| Q2 2021 | $46,000 | -63.2% | 23,005 | -66.3% | 0.00% | – |
| Q1 2021 | $125,000 | +12400.0% | 68,202 | +10794.9% | 0.00% | – |
| Q4 2020 | $1,000 | -80.0% | 626 | -60.7% | 0.00% | – |
| Q3 2020 | $5,000 | -72.2% | 1,591 | -52.1% | 0.00% | – |
| Q4 2019 | $18,000 | +100.0% | 3,322 | -11.1% | 0.00% | – |
| Q3 2019 | $9,000 | – | 3,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |